ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,062, issued on Feb. 17, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).
"AAV compositions" was invented by Eva Fritscher (Vienna), Christian Fiedler (Vienna), Tanvir Tabish (Vienna), Dominik Mittergradnegger (Vienna) and Stefan Reuberger (Vienna).
According to the abstract* released by the U.S. Patent & Trademark Office: "The AAV compositions comprising an AAV and a buffer. These AAV compositions are appropriate for us in intracerebroventricular (ICV) and intraparenchymal (IPA) administration, as well as other routes of administration and can be provided in frozen, liquid or potentially freeze dried (lyophilized) state."
The patent was filed on July 11, 2019, unde...